12:00 AM
 | 
Feb 28, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Generic enalapril and famotidine regulatory update

The FDA granted tentative approval to IVX's generic versions of Vasotec enalapril to treat hypertension and prevent...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >